PAS-positive uNK (upper panels) and GlyTs (lower panels) in placentas. by Hui Zhao (7395)

BIX-01294 attenuates H3K9 methylation and derepresses transcriptional regulation of target genes. by Jolene Caifeng Ho (4597606)

“…<p>(A) Western blots showing decrease in H3K9me1 (MCF-7) and H3K9me2 levels (MCF-7 and HeLa) after 48 and 24 hours respectively in the indicated treatments. …”

Table_1_Immune responses in COVID-19 and tuberculosis coinfection: A scoping review.docx by Kevin Flores-Lovon (13432422)

“…Regarding patients with COVID-19 and active tuberculosis (aTB), they exhibited decreased total lymphocyte counts, CD4 T cells specific against SARS-CoV-2 and responsiveness to SARS-CoV-2 antigens compared to patients with only COVID-19.…”

HE (upper panels) or isolectin B4 (lower panels) staining of labyrinth regions. by Hui Zhao (7395)

Synthetic overview of the impact of ionic and osmotic toxicity on two African rice cultivars. by Hermann Prodjinoto (140121)

“…<p>Plants from the salt-tolerant cultivar TOG5307 and salt-sensitive cultivar TOG5949 were exposed for 7 days to iso-osmotic solution of PEG (12.9%), NaCl (75 mM) or MIX treatment (NaCl 37.5 mM + PEG 6.4%). Direction of the arrow indicates increase or decrease of the corresponding parameter comparatively to non-stressed control of the same cultivar. …”

Defining the next generation of <i>Plasmodium vivax</i> diagnostic tests for control and elimination: Target product profiles by Xavier C. Ding (181347)

“…<i>vivax</i> experts, identified the specific diagnostic needs associated with this species and defined a series of three distinct target product profiles, each aimed at a particular diagnostic application: (i) point-of-care of acutely ill patients for clinical care purposes; (ii) point-of-care asymptomatic and otherwise sub-patent residents for public health purposes, e.g., mass screen and treat campaigns; and (iii) ultra-sensitive not point-of-care diagnosis for epidemiological research/surveillance purposes. …”

Decreased levels of glycosylated α-DG and laminin levels distal to the glial dome in <i>POMGnT1</i>-KO and <i>Large</i>^{<i>myd/myd</i>} mice. by Shigefumi Morioka (8893511)

Impact of iso-osmotic solutions of PEG 12.9%, NaCl 75 mM or MIX treatment (PEG 6.4% + NaCl 37.5 mM) applied for 7 days on relative increase in the number of leaves, relative elonga... by Hermann Prodjinoto (140121)

Effects of diet regimens on pregnant mice. by Hui Zhao (7395)

Therapeutic impact of dietary vitamin D supplementation for preventing right ventricular remodeling and improving survival in pulmonary hypertension by Graham Law (17161852)

Quantitative determination of loss of MMP in Neuro-2a cells in response to Grx1 knockdown. by Uzma Saeed (49670)

“…Cells transfected with empty vector show abrupt decrease in TMRM intensity after CCCP treatment representing sudden loss of MMP (A). …”

A: Incidence of SWDs (mean ± S.E.M.) per 30 min in various phases of the experiment. by Francesca Scicchitano (782062)

Effects of chronic PG-LPS infusion on cardiac myocyte apoptosis. by Kenichi Kiyomoto (12709675)

Effects of chronic PG-LPS infusion on Ang II and the weights of cardiac muscle, lung and liver. by Kenichi Kiyomoto (12709675)

Impact of iso-osmotic solutions of PEG 12.9%, NaCl 75 mM or MIX treatment (PEG 6.4% + NaCl 37.5 mM) applied for 1 or 7 days on maximal efficiency of PSII photochemistry in the dark... by Hermann Prodjinoto (140121)

List of primers corresponding to <i>OsHKT1</i>.<i>5</i>, <i>OsHKT1</i>.<i>1</i>, <i>OsSOS1</i>, <i>OsSOS2</i>, <i>OsNHX1</i>, <i>OsNHX2</i>, <i>OsNRT1</i>, <i>OsCLC</i>, <i>OsCCC1<... by Hermann Prodjinoto (140121)

Table_1_Treatment of multiple sclerosis with rituximab: A Spanish multicenter experience.DOCX by Francisco Gascón-Giménez (12266840)

“…Mean EDSS had increased from 4.3 (SD: 1.9) to 4.8 (SD: 1.7) and almost half of the patients (41%) had worsened at least one point. After a median follow-up of 14.2 months (IQR: 6.5–27.2), ARR decreased by 85.7% (p < 0.001) and GEL by 82.9%, from 0.41 to 0.07 (p < 0.001). …”

Table_1_Treatment of multiple sclerosis with rituximab: A Spanish multicenter experience.DOCX by Francisco Gascón-Giménez (12266840)

“…Mean EDSS had increased from 4.3 (SD: 1.9) to 4.8 (SD: 1.7) and almost half of the patients (41%) had worsened at least one point. After a median follow-up of 14.2 months (IQR: 6.5–27.2), ARR decreased by 85.7% (p < 0.001) and GEL by 82.9%, from 0.41 to 0.07 (p < 0.001). …”

Sampling map. by Emmanuel Corse (402278)

When the CSF glucose concentration is increased, the release of secretory granules by SCO cells is decreased in GLUT2^loxP/loxP mice after genetic inactivation of GLUT2. by Francisco Nualart (231550)